Guardian Pharmacy Services (GRDN) Depreciation & Amortization (CF) (2023 - 2026)

Guardian Pharmacy Services has disclosed Depreciation & Amortization (CF) across 4 years of filings, most recently posting $5.8 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) rose 5.83% year-over-year to $5.8 million; the TTM figure through Jun 2026 stood at $23.4 million (up 11.77% YoY), while the FY2025 annual figure was $22.3 million, up 12.96% from the prior year.
• Depreciation & Amortization (CF) came in at $5.8 million for Q2 2026 at Guardian Pharmacy Services, down from $6.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $6.0 million in Q1 2026 to a low of $4.7 million in Q4 2023.
• Average Depreciation & Amortization (CF) over 4 years is $5.3 million, with a median of $5.3 million recorded in 2025.
• Year-over-year, Depreciation & Amortization (CF) rose 16.9% in 2025 and gained 5.83% in 2026.
• Over 4 years, Depreciation & Amortization (CF) stood at $4.7 million in 2023, then increased by 9.31% to $5.2 million in 2024, then gained by 11.41% to $5.7 million in 2025, then rose by 1.18% to $5.8 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $5.8 million in Q2 2026, $6.0 million in Q1 2026, and $5.7 million in Q4 2025.